Interlock Medizintechnik and Key Surgical have merged to form a major global supplier of sterile processing and operating room supplies.
The newly combined company also gains products from Clinipak, a UK-based provider acquired by Interlock last year. Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, led the merger of the European and US firms and invested in the newly combined company.
Interlock is a European provider to central sterile supply departments. Clinipak is a manufacturer and distributor of central sterile supplies in the United Kingdom. Key Surgical is a US provider of products that clean, protect and identify surgical instruments.
As one company, Interlock, Clinipak and Key Surgical say they will offer a broad range of sterile processing and operating room products and supplies to nearly 10,000 hospitals and surgical centres around the world.
Mads Fiig, managing director, European operations, Interlock, said: “We are tremendously excited about the combination of our companies and the benefits it will bring to our customers. Interlock, Clinipak and Key Surgical are highly regarded throughout Europe and the United Stated for our expertise, broad product offering and exceptional customer service.
“Together, we will offer hospitals and surgical centres a comprehensive portfolio of products and supplies that support the industry’s highest quality standards for patient care and safety in the surgical setting.”
Gerhard Baum, co-founder of Interlock, added: “We have the unique opportunity to bring together three highly respected, high-quality brands that are market leaders in their respective countries.
“As one entity, Interlock, Clinipak and Key Surgical will be the only global organisation dedicated to providing hospitals with products and supplies that support their goals for surgical and patient safety.
“In addition, our partnership with Water Street will allow us to gain access to a highly regarded team with deep medical product and distribution expertise and a network of resources to support our growth.”
Scot Milchman, CEO of Key Surgical, added, “It’s clear that increasing numbers of hospitals are investing in infection prevention and patient safety initiatives.
“The combination of Interlock, Clinipak and Key Surgical creates a strong and extensive global platform for us to build on.
“We plan to work together to invest in the company’s infrastructure and pursue acquisition opportunities that will strategically expand our product portfolio and geographic footprint.”
Mr. Milchman will serve as CEO of the newly combined company, Brian O’Connell as president and COO, and John Savage as CFO.
Mr. Fiig, a longtime healthcare executive, will serve as managing director of European operations. Mr. Baum, one of the founders of Interlock, will remain with the company to focus on customer and supplier relationships.
Key Surgical, Interlock and Clinipak will continue to operate and serve customers under their existing names and brands.
Financial terms of the merger are not being disclosed.
